Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy
Author:
Funder
Ministry of Trade, Industry and Energy
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdy055/23857195/mdy055.pdf
Reference25 articles.
1. Paclitaxel Gastric Cancer Study Group in Japan. Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer;Yamaguchi;Gastric Cancer,2002
2. Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after failure of prior combination chemotherapy using fluoropyrimidine plus platinum: wJOG 4007 trial;Hironaka;JCO,2013
3. Limited oral bioavailability and active epithelial secretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine;Sparreboom;Proc Natl Acad Sci USA,1997
4. Clinical pharmacology and metabolism of Taxol (paclitaxel): update 1993;Rowinsky;Ann Oncol,1994
5. Variability in human cytochrome P450 paclitaxel metabolism;Sonnichsen;J Pharmacol Exp Ther,1995
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Innovative strategies for effective paclitaxel delivery: Recent developments and prospects;Journal of Oncology Pharmacy Practice;2024-01-10
2. Anti-cancer effects of DHP107 on canine mammary gland cancer examined through in-vitro and in-vivo mouse xenograft models;BMC Veterinary Research;2024-01-03
3. Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma;Biomedicines;2023-10-25
4. pH-responsive PLGA/gelatin porous microspheres containing paclitaxel used for inhibition of cancer cell proliferation;Journal of Drug Delivery Science and Technology;2023-09
5. Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study;European Journal of Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3